Kopsidas Konstantinos, Mudhar Hardeep, Sisley Karen, Hammond David W, Worthington L, Suvarna Kim, Foran Bernadette, Salvi Sachin
Sheffield Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
National Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Ocul Oncol Pathol. 2019 Feb;5(2):79-84. doi: 10.1159/000487805. Epub 2018 May 7.
To describe the clinical and histopathological features of an aggressive ciliary body adenocarcinoma with pulmonary metastases and skull base spread.
A 45-year-old female patient presented with a post-traumatic phthisical eye that was eviscerated. This showed an unexpected carcinoma (positive for cytokeratins and melanocytic markers), the histological differential diagnosis for which included a primary ciliary body adenocarcinoma or a metastasis. The patient developed rapid post-surgical localized recurrence that required an orbital exenteration. This showed identical tumour to the evisceration specimen, with vascular invasion in orbital blood vessels and a contaminated orbital soft tissue margin. Staging imaging revealed multiple lung metastases, which were biopsied and shown to be a disseminated ciliary body adenocarcinoma rather than a disseminated primary lung carcinoma. The tumour spread locally to the skull base for which radiotherapy was given. Unfortunately, the patient passed away a few weeks later.
To our knowledge, this is the first case of ciliary body adenocarcinoma with bilateral lung metastases. The malignant potential of these tumours should be considered as a possibility, and appropriate screening and staging tests should therefore be considered to guide appropriate management.
描述一例具有肺转移和颅底扩散的侵袭性睫状体腺癌的临床和组织病理学特征。
一名45岁女性患者因外伤后眼球痨而接受眼球摘除术。术后病理显示为意外发现的癌(细胞角蛋白和黑素细胞标记物呈阳性),其组织学鉴别诊断包括原发性睫状体腺癌或转移瘤。患者术后迅速出现局部复发,需要进行眶内容剜除术。术后病理显示肿瘤与眼球摘除标本相同,侵犯眼眶血管且眼眶软组织切缘受侵。分期影像学检查发现多处肺转移,经活检证实为播散性睫状体腺癌而非原发性肺癌肺转移。肿瘤局部扩散至颅底并接受了放疗。不幸的是,患者几周后去世。
据我们所知,这是首例伴有双侧肺转移的睫状体腺癌。应考虑这些肿瘤具有恶性潜能的可能性,因此应考虑进行适当的筛查和分期检查以指导恰当的治疗。